Elizabeth M Berry-Kravis (Elizabeth Berry-Kravis)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Topics

Autism Spectrum Disorder

Lipopolysaccharide Induced

Obstructive Sleep Apnea

Top Venues

Nature medicine

Science advances

American journal of medical genetics. Part A

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jorrit Tjeertes, Carlos A Bacino, Terry Jo Bichell, Lynne M Bird, Mariana Bustamante, Rebecca Crean, Shafali Jeste, Robert W Komorowski, Michelle L Krishnan, Meghan T Miller, David Nobbs, Cesar Ochoa-Lubinoff, Kimberly A Parkerson, Alexander Rotenberg, Anjali Sadhwani, Mark D Shen, Lisa Squassante, Wen-Hann Tan, Brenda Vincenzi, Anne C Wheeler, Joerg F Hipp, Elizabeth M Berry-Kravis
Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS). Journal of neurodevelopmental disorders 15 (1) (2023)
Jeffrey Lorenz Neul, Alan K Percy, Timothy A Benke, Elizabeth M Berry-Kravis, Daniel G Glaze, Eric D Marsh, Tim Lin, Serge Stankovic, Kathie M Bishop, James M Youakim
Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study. Nature medicine (2023)
Elizabeth M Berry-Kravis
Disease-Targeted Treatment Translation in Fragile X Syndrome as a Model for Neurodevelopmental Disorders. Journal of child neurology 37 (10-11) (2022)
Dejan B Budimirovic, Dragana D Protic, Carol M Delahunty, Howard F Andrews, Tse-Hwei Choo, Qing Xu, Elizabeth M Berry-Kravis, Walter E Kaufmann, null null
Sleep problems in fragile X syndrome: Cross-sectional analysis of a large clinic-based cohort. American journal of medical genetics. Part A (2021)
Elizabeth M Berry-Kravis, Mark D Harnett, Scott A Reines, Melody A Reese, Lauren E Ethridge, Abigail H Outterson, Claire Michalak, Jeremiah Furman, Mark E Gurney
Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial. Nature medicine 27 (5) (2021)
John V Pluvinage, Jerry Sun, Christel Claes, Ryan A Flynn, Michael S Haney, Tal Iram, Xiangling Meng, Rachel Lindemann, Nicholas M Riley, Emma Danhash, Jean Paul Chadarevian, Emma Tapp, David Gate, Sravani Kondapavulur, Inma Cobos, Sundari Chetty, Anca M Pașca, Sergiu P Pașca, Elizabeth M Berry-Kravis, Carolyn R Bertozzi, Mathew Blurton Jones, Tony Wyss-Coray
The CD22-IGF2R interaction is a therapeutic target for microglial lysosome dysfunction in Niemann-Pick type C. Science translational medicine 13 (622) (2021)
Alexander Kolevzon, Elsa Delaby, Elizabeth M Berry-Kravis, Joseph D Buxbaum, Catalina Betancur
Neuropsychiatric decompensation in adolescents and adults with Phelan-McDermid syndrome: a systematic review of the literature. Molecular autism 10 (2019)
Arezoo Movaghar, David Page, Murray Brilliant, Mei Wang Baker, Jan Greenberg, Jinkuk Hong, Leann Smith DaWalt, Krishanu Saha, Finn Kuusisto, Ron Stewart, Elizabeth M Berry-Kravis, Marsha R Mailick
Data-driven phenotype discovery of FMR1 premutation carriers in a population-based sample. Science advances 5 (8) (2019)